A case of logopenic primary progressive aphasia with C9ORF72 expansion and cortical florbetapir binding

J Alzheimers Dis. 2014;42(2):413-20. doi: 10.3233/JAD-140222.

Abstract

We report the case of a 65-year-old woman, clinically diagnosed with the logopenic variant of primary progressive aphasia (PPA), and carrier of C9ORF72 expansion, despite cerebrospinal fluid biomarkers suggesting Alzheimer's disease (AD). She underwent structural MRI, metabolic PET, and amyloid PET imaging using florbetapir. Comparison with healthy controls revealed widespread hypometabolism, left sided cortical atrophy, and an increased cortical amyloid load. No difference in amyloid binding was found between the patient and predemential AD patients. This case provides evidence of amyloidopathy in a carrier of C9ORF72 expansion exhibiting a clinical profile of the logopenic variant of PPA.

Keywords: Alzheimer's disease; C9ORF72 expansion; florbetapir; logopenic primary aphasia.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Aphasia, Primary Progressive / genetics*
  • Aphasia, Primary Progressive / pathology*
  • Brain Mapping*
  • C9orf72 Protein
  • Cerebral Cortex / pathology*
  • Female
  • Fluorodeoxyglucose F18
  • Humans
  • Imaging, Three-Dimensional
  • Magnetic Resonance Imaging
  • Positron-Emission Tomography
  • Proteins / genetics*

Substances

  • C9orf72 Protein
  • C9orf72 protein, human
  • Proteins
  • Fluorodeoxyglucose F18